论文信息 - Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. - 字舞流文

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial.

S. Yancey | C. Bachert | W. Fokkens | M. Wagenmann | C. Hopkins | M. Desrosiers | Joseph K. Han | Stella E. Lee | B. Mayer | N. Martin | R. Chan | A. Sousa | Steven G. Smith